RNA Metabolism in T Lymphocytes
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
RNA metabolism plays a central role in regulating of T cell-mediated immunity. RNA processing, modifications, and regulations of RNA decay influence the tight and rapid regulation of gene expression during T cell phase transition. Thymic selection, quiescence maintenance, activation, differentiation, and effector functions of T cells are dependent on selective RNA modulations. Recent technical improvements have unveiled the complex crosstalk between RNAs and T cells. Moreover, resting T cells contain large amounts of untranslated mRNAs, implying that the regulation of RNA metabolism might be a key step in controlling gene expression. Considering the immunological significance of T cells for disease treatment, an understanding of RNA metabolism in T cells could provide new directions in harnessing T cells for therapeutic implications.
Abstract
RNA metabolism plays a central role in regulating of T cell-mediated immunity. RNA processing, modifications, and regulations of RNA decay influence the tight and rapid regulation of gene expression during T cell phase transition. Thymic selection, quiescence maintenance, activation, differentiation, and effector functions of T cells are dependent on selective RNA modulations. Recent technical improvements have unveiled the complex crosstalk between RNAs and T cells. Moreover, resting T cells contain large amounts of untranslated mRNAs, implying that the regulation of RNA metabolism might be a key step in controlling gene expression. Considering the immunological significance of T cells for disease treatment, an understanding of RNA metabolism in T cells could provide new directions in harnessing T cells for therapeutic implications.
참고문헌 (99)
- Beyer AL, "Splice site selection, rate of splicing, and alternative splicing on nascent transcripts", Genes Dev, 2, pp.754~765 (1988)
- Bird G, "RNA polymerase II carboxy-terminal domain phosphorylation is required for cotranscriptional pre-mRNA splicing and 3′-end formation", Mol Cell Biol, 24, pp.8963~8969 (2004)
- Nagaike T, "Transcriptional activators enhance polyadenylation of mRNA precursors", Mol Cell, 41, pp.409~418 (2011)
- Han D, "Antitumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells", Nature, 566, pp.270~274 (2019)
- Tong J, "m6A mRNA methylation sustains Treg suppressive functions", Cell Res, 28, pp.253~256 (2018)
- Love PE, "Signal integration and crosstalk during thymocyte migration and emigration", Nat Rev Immunol, 11, pp.469~477 (2011)
- Chapman NM, "Metabolic coordination of T cell quiescence and activation", Nat Rev Immunol, 20, pp.55~70 (2020)
- Chapman NM, "Hallmarks of t-cell exit from quiescence", Cancer Immunol Res, 6, pp.502~508 (2018)
- Jeong-Ryul Hwang, "Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development", Experimental and Molecular Medicine, 52, pp.1~12 (2020), 생화학분자생물학회[DOI]
- Kaech SM, "Effector and memory T-cell differentiation : implications for vaccine development", Nat Rev Immunol, 2, pp.251~262 (2002)
- Gebert LF, "Regulation of microRNA function in animals", Nat Rev Mol Cell Biol, 20, pp.21~37 (2019)
- Baumjohann D, "MicroRNA-mediated regulation of T helper cell differentiation and plasticity", Nat Rev Immunol, 13, pp.666~678 (2013)
- Davari K, "Rapid genome-wide recruitment of RNA polymerase ii drives transcription, splicing, and translation events during t cell responses", Cell Reports, 19, pp.643~654 (2017)
- Araki K, "Translation is actively regulated during the differentiation of CD8+ effector T cells", Nat Immunol, 18, pp.1046~1057 (2017)
- Wolf T, "Dynamics in protein translation sustaining T cell preparedness", Nat Immunol, 21, pp.927~937 (2020)
- Ricciardi S, "The translational machinery of human CD4+ T cells is poised for activation and controls the switch from quiescence to metabolic remodeling", Cell Metab, 28, pp.895~906 (2018)
- Pan Q, "Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing", Nat Genet, 40, pp.1413~1415 (2008)
- Wang ET, "Alternative isoform regulation in human tissue transcriptomes", Nature, 456, pp.470~476 (2008)
- Jacob AG, "Intron retention as a component of regulated gene expression programs", Hum Genet, 136, pp.1043~1057 (2017)
- Martinez NM, "Alternative splicing networks regulated by signaling in human T cells", RNA, 18, pp.1029~1040 (2012)
- Lau CI, "The pioneer transcription factors Foxa1 and Foxa2 regulate alternative RNA splicing during thymocyte positive selection", Development, 148, pp.dev199754~ (2021)
- Whisenant TC, "The activation-induced assembly of an RNA", protein interactome centered on the splicing factor U2AF2 regulates gene expression in human CD4 T cells, 2015, pp.10, e0144409~
- Qi Z, "SRSF1 serves as a critical posttranscriptional regulator at the late stage of thymocyte development", Sci Adv, 7, pp.eabf0753~ (2021)
- Katsuyama T, "Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity", J Clin Invest, 129, pp.5411~5423 (2019)
- Marasca F, "LINE1 are spliced in non-canonical transcript variants to regulate T cell quiescence and exhaustion", Nat Genet, 54, pp.180~193 (2022)
- La Porta J, "The rna-binding protein, polypyrimidine tract-binding protein 1(PTBP1)is a key regulator of CD4 T cell activation", PLoS One, 11, pp.e0158708~ (2016)
- Dasgupta T, "The importance of CELF control : molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins", Wiley Interdiscip Rev RNA, 3, pp.104~121 (2012)
- Mallory MJ, "Induced transcription and stability of CELF2 mRNA drives widespread alternative splicing during T-cell signaling", Proc Natl Acad Sci U S A, 112, pp.E2139~E2148 (2015)
- Dong C, "JNK is required for effector T-cell function but not for T-cell activation", Nature, 405, pp.91~94 (2000)
- Matsuda S, "T lymphocyte activation signals for interleukin-2production involve activation of MKK6-p38 and MKK7-SAPK", JNK signaling pathways sensitive to cyclosporin A, 1998, pp.273, 12378~12382
- Martinez NM, "Widespread JNKdependent alternative splicing induces a positive feedback loop through CELF2-mediated regulation of MKK7 during T-cell activation", Genes Dev, 29, pp.2054~2066 (2015)
- Mallory MJ, "Signal-and development-dependent alternative splicing of LEF1 in T cells is controlled by CELF2", Mol Cell Biol, 31, pp.2184~2195 (2011)
- Bruhn L, "ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function", Genes Dev, 11, pp.640~653 (1997)
- Yoshida H, "The immunobiology of interleukin-27", Annu Rev Immunol, 33, pp.417~443 (2015)
- da Glória VG, "T cell activation regulates CD6 alternative splicing by transcription dynamics and SRSF1", J Immunol, 193, pp.391~399 (2014)
- Hawse WF, "TCR signal strength regulates Akt substrate specificity to induce alternate murine Th and T regulatory cell differentiation programs", J Immunol, 199, pp.589~597 (2017)
- Bhattacharyya ND, "Regulation of T helper cell fate by TCR signal strength", Front Immunol, 11, pp.624~ (2020)
- Meininger I, "Alternative splicing of MALT1 controls signalling and activation of CD4+ T cells", Nat Commun, 7, pp.11292~ (2016)
- Fry TJ, "The many faces of IL-7 : from lymphopoiesis to peripheral T cell maintenance", J Immunol, 174, pp.6571~6576 (2005)
- Gregory SG, "Interleukin 7 receptor alpha chain(IL7R)shows allelic and functional association with multiple sclerosis", Nat Genet, 39, pp.1083~1091 (2007)
- Galarza-Muñoz G, "Human epistatic interaction controls IL7R splicing and increases multiple sclerosis risk", Cell, 169, pp.72~84 (2017)
- Middleton R, "IRFinder : assessing the impact of intron retention on mammalian gene expression", Genome Biol, 18, pp.51~ (2017)
- Cho V, "The RNAbinding protein hnRNPLL induces a T cell alternative splicing program delineated by differential intron retention in polyadenylated RNA", Genome Biol, 15, pp.R26~ (2014)
- Ni T, "Global intron retention mediated gene regulation during CD4+ T cell activation", Nucleic Acids Res, 44, pp.6817~6829 (2016)
- Zhao BS, "Post-transcriptional gene regulation by mRNA modifications", Nat Rev Mol Cell Biol, 18, pp.31~42 (2017)
- Cao G, "Recent advances in dynamic m6A RNA modification", Open Biol, 6, pp.160003~ (2016)
- Fu Y, "Gene expression regulation mediated through reversible m6A RNA methylation", Nat Rev Genet, 15, pp.293~306 (2014)
- Ke S, "A majority of m6A residues are in the last exons, allowing the potential for 3′ UTR regulation", Genes Dev, 29, pp.2037~2053 (2015)
- Liu J, "A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation", Nat Chem Biol, 10, pp.93~95 (2014)
- Liu N, "N6-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions", Nature, 518, pp.560~564 (2015)
- Wang X, "N6-methyladenosine modulates messenger RNA translation efficiency", Cell, 161, pp.1388~1399 (2015)
- Du H, "YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex", Nat Commun, 7, pp.12626~ (2016)
- Li HB, "m6A mRNA methylation controls T cell homeostasis by targeting the IL-7", STAT5, Nature, pp.2017, 548[DOI]
- Zhu Y, "The E3 ligase VHL promotes follicular helper T cell differentiation via glycolytic-epigenetic control", J Exp Med, 216, pp.1664~1681 (2019)
- Yao Y, "METTL3-dependent m6A modification programs T follicular helper cell differentiation", Nat Commun, 12, pp.1333~ (2021)
- Zhou J, "M6A demethylase ALKBH5controls CD4+ T cell pathogenicity and promotes autoimmunity", Sci Adv, 7, pp.eabg0470~ (2021)
- Zhang Y, "Impaired DNA methylation and its mechanisms in CD4+ T cells of systemic lupus erythematosus", J Autoimmun, 41, pp.92~99 (2013)
- Dominissini D, "The dynamic N1-methyladenosine methylome in eukaryotic messenger RNA", Nature, 530, pp.441~446 (2016)
- Rak R, "Dynamic changes in tRNA modifications and abundance during T cell activation", Proc Natl Acad Sci U S A, 118, pp.118~ (2021)
- Otero DC, "IRF7-dependent IFN-β production in response to RANKL promotes medullary thymic epithelial cell development", J Immunol, 190, pp.3289~3298 (2013)
- Wu B, "Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5", Cell, 152, pp.276~289 (2013)
- Liddicoat BJ, "RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself", Science, 349, pp.1115~1120 (2015)
- Nakahama T, "ADAR1-mediated RNA editing is required for thymic self-tolerance and inhibition of autoimmunity", EMBO Rep, 19, pp.e46303~ (2018)
- Gutiérrez-Vázquez C, "3′ Uridylation controls mature microRNA turnover during CD4 T-cell activation", RNA, 23, pp.882~891 (2017)
- Furuichi Y, "5′-Terminal structure and mRNA stability", Nature, 266, pp.235~239 (1977)
- Bernstein P, "Poly(A), poly(A)binding protein and the regulation of mRNA stability", Trends Biochem Sci, 14, pp.373~377 (1989)
- Doidge R, "Deadenylation of cytoplasmic mRNA by the mammalian CCR4-NOT complex", Biochem Soc Trans, 40, pp.896~901 (2012)
- Wang Z, "The hDcp2 protein is a mammalian mRNA decapping enzyme", Proc Natl Acad Sci U S A, 99, pp.12663~12668 (2002)
- Beelman CA, "An essential component of the decapping enzyme required for normal rates of mRNA turnover", Nature, 382, pp.642~646 (1996)
- Mao R, "Regnase-1, a rapid response ribonuclease regulating inflammation and stress responses", Cell Mol Immunol, 14, pp.412~422 (2017)
- Yang F, "Endonuclease-mediated mRNA decay requires tyrosine phosphorylation of polysomal ribonuclease 1(PMR1)for the targeting and degradation of polyribosome-bound substrate mRNA", J Biol Chem, 279, pp.48993~49002 (2004)
- Ito-Kureha T, "The CCR4-NOT deadenylase complex safeguards thymic positive selection by down-regulating aberrant pro-apoptotic gene expression", Nat Commun, 11, pp.6169~ (2020)
- Brooks SA, "Tristetraprolin(TTP) : interactions with mRNA and proteins, and current thoughts on mechanisms of action", Biochim Biophys Acta, 1829, pp.666~679 (2013)
- Sandler H, "Not1 mediates recruitment of the deadenylase Caf1 to mRNAs targeted for degradation by tristetraprolin", Nucleic Acids Res, 39, pp.4373~4386 (2011)
- Ciofani M, "Stage-specific and differential notch dependency at the αβ and γδ T lineage bifurcation", Immunity, 25, pp.105~116 (2006)
- Hodson DJ, "Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia", Nat Immunol, 11, pp.717~724 (2010)
- Vogel KU, "The RNA-binding proteins zfp36l1 and zfp36l2enforce the thymic beta-selection checkpoint by limiting DNA damage response signaling and cell cycle progression", J Immunol, 197, pp.2673~2685 (2016)
- Galloway A, "Cell cycle RNA regulons coordinating early lymphocyte development", Wiley Interdiscip Rev RNA, 8, pp.e1419~ (2017)
- Salerno F, "Translational repression of pre-formed cytokine-encoding mRNA prevents chronic activation of memory T cells", Nat Immunol, 19, pp.828~837 (2018)
- Moore MJ, "ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity", Elife, 7, pp.e33057~ (2018)
- Heissmeyer V, "Molecular control of Tfh-cell differentiation by Roquin family proteins", Immunol Rev, 253, pp.273~289 (2013)
- Vogel KU, "Roquin paralogs 1 and 2 redundantly repress the Icos and Ox40 costimulator mRNAs and control follicular helper T cell differentiation", Immunity, 38, pp.655~668 (2013)
- Glasmacher E, "Roquin binds inducible costimulator mRNA and effectors of mRNA decay to induce microRNA-independent post-transcriptional repression", Nat Immunol, 11, pp.725~733 (2010)
- Choi YS, "ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6", Immunity, 34, pp.932~946 (2011)
- Vinuesa CG, "A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity", Nature, 435, pp.452~458 (2005)
- Yu D, "Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA", Nature, 450, pp.299~303 (2007)
- Hwang SS, "mRNA destabilization by BTG1 and BTG2 maintains T cell quiescence", Science, 367, pp.1255~1260 (2020)
- Mino T, "Regnase-1 and roquin regulate a common element in inflammatory mRNAs by spatiotemporally distinct mechanisms", Cell, 161, pp.1058~1073 (2015)
- Matsushita K, "Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay", Nature, 458, pp.1185~1190 (2009)
- Uehata T, "Malt1-induced cleavage of regnase-1 in CD4+ helper T cells regulates immune activation", Cell, 153, pp.1036~1049 (2013)
- Kong G, "Transgenic expression of a mutant ribonuclease regnase-1in T cells disturbs T cell development and functions", Front Immunol, 12, pp.682220~ (2021)
- Jeltsch KM, "Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote TH17 differentiation", Nat Immunol, 15, pp.1079~1089 (2014)
- Lisy S, "Rna binding proteins as pioneer determinants of infection : protective, proviral, or both", Viruses, 13, pp.2172~ (2021)
- Berkovits BD, "Alternative 3′ UTRs act as scaffolds to regulate membrane protein localization", Nature, 522, pp.363~367 (2015)
- Papadaki O, "Control of thymic T cell maturation, deletion and egress by the RNA-binding protein HuR", J Immunol, 182, pp.6779~6788 (2009)
- DeMicco A, "Lymphocyte lineage-specific and developmental stage specific mechanisms suppress cyclin D3 expression in response to DNA double strand breaks", Cell Cycle, 15, pp.2882~2894 (2016)
- Techasintana P, "The RNA-binding protein HuR posttranscriptionally regulates IL-2 homeostasis and CD4+ Th2 differentiation", Immunohorizons, 1, pp.109~123 (2017)
- Gubin MM, "Conditional knockout of the RNA-binding protein HuR in CD4+ T cells reveals a gene dosage effect on cytokine production", Mol Med, 20, pp.93~108 (2014)
- Chen J, "Posttranscriptional gene regulation of IL-17 by the RNA-binding protein HuR is required for initiation of experimental autoimmune encephalomyelitis", J Immunol, 191, pp.5441~5450 (2013)
